Dutch Lady Milk Industries Bhd posted a net profit of approximately RM38.2 million for the second quarter ended June 30, 2026, a 63.2% increase from a year earlier, marking its highest quarterly profit in five years [1, 2, 3, 4]. Revenue for the quarter rose about 3% to RM386.6 million, driven mainly by strong sales of its core liquid milk products, which were relaunched with new packaging [1, 2, 3, 4].

For the six months ended June 30, 2026, Dutch Lady’s net profit increased 40.7% to roughly RM68.1 million, while revenue climbed 4.7% to RM784.4 million [1, 2, 4]. Company officials attributed profit growth to revenue expansion, favorable exchange rate effects, and the absence of one-off transition costs that affected last year’s results [1, 2, 4].

The company highlighted strong momentum in the out-of-home food service channel and positive contributions from innovative products such as Dutch Lady Omega 3*6 and the new Dutch Lady Tealive range. "Strong momentum in the out-of-home channel as well as positive contribution from innovations... have also supported our performance," the company said [3, 4].

Dutch Lady completed the full transition of production to its new IR4.0 Manufacturing Facility and Distribution Centre in Bandar Enstek, which the company said enhances operational efficiency and supply chain resilience. "The strategic capacity expansion enhances operational efficiency and opens opportunities to strengthen DLMI’s position in the Malaysian dairy industry," the company added [3].

The company emphasized continued efforts to manage costs, raw material supply, and working capital amid inflation and changing consumer spending patterns [1, 2]. It also reduced its outstanding intercompany loan balance to US$7.0 million after repaying US$15.1 million in the quarter, reflecting strong cash flow and lower capital expenditures [3].

Dutch Lady shares closed unchanged at RM31.50 on August 18, 2026, with a market capitalization of about RM2.02 billion [1, 2].

The company did not declare any dividends with the latest results [1, 2].